HMG co-reductase inhibitor

Details HMG co-reductase inhibitor HMG co-reductase inhibitor

1997-12-12

1999-06-29

Dees, Jose' G.

Drug, bio-affecting and body treating compositions

Preparations characterized by special physical form

Tablets, lozenges, or pills

514529, A61K 936

Patent

active

059165952

ABSTRACT:
A controlled release dosage formulation is described which is based on a combination of:

REFERENCES:
patent: 4814183 (1989-03-01), Zentner
patent: 4915954 (1990-04-01), Ayer et al.
patent: 4946686 (1990-08-01), McClelland et al.
patent: 4976967 (1990-12-01), McClelland et al.
patent: 5244916 (1993-09-01), Bokoch
patent: 5300288 (1994-04-01), Albright
patent: 5350584 (1994-09-01), McClelland et al.
patent: 5366738 (1994-11-01), Rork et al.
patent: 5518730 (1996-05-01), Fuisz
patent: 5543154 (1996-08-01), Rork et al.
patent: 5582838 (1996-12-01), Rork et al.
patent: 5616593 (1997-04-01), Patel et al.
Hatano, Harumi et al., Pharmaceutical Preparation inform of Coated Capsule Releasable at Lower Part of Digestive Tract, Caplus, 1997:195672.

Affiliated with

Also associated with

Rating

HMG co-reductase inhibitor does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with HMG co-reductase inhibitor, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and HMG co-reductase inhibitor will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1373940